Oliwia Wróblewska
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Oliwia Wróblewska has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Jakub Majewski
Hospital Murcki Limited Liability Company, Katowice, Poland
11 shared publications - Aleksandra Romaniuk
Regional Specialist Hospital in Biała Podlaska, Poland
8 shared publications - Anna Karcz
Beskid Oncology Center - Municipal Hospital of John Paul II in Bielsko-Biała, Poland
8 shared publications - Artur Koza
Regional Specialist Hospital in Biała Podlaska, Poland
8 shared publications - Barbara Pająk
Beskid Oncology Center - Municipal Hospital of John Paul II in Bielsko-Biała, Poland
8 shared publications - Hubert Bołdys-Żegocki
Medical University of Silesia in Katowice, Katowice, Poland
8 shared publications
Latest Publications
- Open Access
- 28 September 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (3(51))
OBESITY, ENDOMETRIOSIS, AND GLP-1 RECEPTOR AGONISTS: A NARRATIVE REVIEW
Endometriosis is a chronic, estrogen-dependent inflammatory disease affecting approximately 10% of women of reproductive age and is one of the leading causes of chronic pelvic pain and infertility. The relationship between obesity and endometriosis remains controversial. Although epidemiological studies indicate that endometriosis is diagnosed less frequently in women with a higher body mass index (BMI), excessive adipose tissue may promote disease progression through hormonal disturbances, chronic inflammation, and altered metabolic activity of adipose tissue. This review summarizes the current evidence regarding the mechanisms linking obesity and endometriosis and discusses the potential role of glucagon-like peptide-1 receptor agonists (GLP-1RAs) in the treatment of this disease. In addition to their well-established efficacy in the management of obesity and type 2 diabetes, GLP-1RAs have been shown to promote weight loss, improve metabolic parameters, and reduce chronic inflammation. Available experimental and observational evidence suggests that these mechanisms may indirectly influence the course of endometriosis by modulating the chronic inflammation and the metabolic disturbances associated with obesity. To date, no randomized clinical trials have evaluated the efficacy of GLP-1 receptor agonists in women with endometriosis, and most of the available evidence is derived from preclinical studies, observational studies, and analyses conducted in patients with polycystic ovary syndrome (PCOS). Current evidence suggests that GLP-1RAs represent a promising area of research; however, their role in the treatment of endometriosis requires confirmation in well-designed clinical trials.
- 28 September 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (3(51))
Open AccessOBESITY, ENDOMETRIOSIS, AND GLP-1 RECEPTOR AGONISTS: A NARRATIVE REVIEW
Endometriosis is a chronic, estrogen-dependent inflammatory disease affecting approximately 10% of women of reproductive age and is one of the leading causes of chronic pelvic pain and infertility. The relationship between obesity and endometriosis remains controversial. Although epidemiological studies indicate that endometriosis is diagnosed less frequently in women with a higher body mass index (BMI), excessive adipose tissue may promote disease progression through hormonal disturbances, chronic inflammation, and altered metabolic activity of adipose tissue. This review summarizes the current evidence regarding the mechanisms linking obesity and endometriosis and discusses the potential role of glucagon-like peptide-1 receptor agonists (GLP-1RAs) in the treatment of this disease. In addition to their well-established efficacy in the management of obesity and type 2 diabetes, GLP-1RAs have been shown to promote weight loss, improve metabolic parameters, and reduce chronic inflammation. Available experimental and observational evidence suggests that these mechanisms may indirectly influence the course of endometriosis by modulating the chronic inflammation and the metabolic disturbances associated with obesity. To date, no randomized clinical trials have evaluated the efficacy of GLP-1 receptor agonists in women with endometriosis, and most of the available evidence is derived from preclinical studies, observational studies, and analyses conducted in patients with polycystic ovary syndrome (PCOS). Current evidence suggests that GLP-1RAs represent a promising area of research; however, their role in the treatment of endometriosis requires confirmation in well-designed clinical trials.
- Open Access
- 17 August 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 69
From Monitoring to Prevention: Wearable Technology for Injury Prevention in Sport: A Narrative Review
Background Wearable technologies are used in sport to monitor training load, biomechanics, physiology, and recovery, but their effectiveness in injury prevention remains uncertain. Aim To evaluate evidence on wearables for sports injury prevention using a framework covering measurement validity, injury association, prognostic modelling, implementation, and intervention effectiveness. Material and methods A narrative review of wearables monitoring modifiable injury-related factors was conducted. Findings were organized across five translational levels, from measurement validity to injury reduction, following SANRA recommendations [20]. Results Validity and reliability depend on the device, algorithm, sensor placement, and sporting task. Associations between wearable-derived metrics and injuries are inconsistent and do not support universal risk thresholds. Machine-learning models show promise, but their use is limited by poor external validation, calibration, and methods. Implementation, organizational context, and human decision-making affect practical value. Direct evidence that wearable-guided interventions reduce injuries remains scarce. Conclusions Wearables should be viewed as monitoring and decision-support tools rather than autonomous injury-prevention systems. Evidence is strongest for measurement and weakens toward injury reduction. Future research should prioritize multicentre validation, causal modelling, standardized reporting, and pragmatic trials.
- 17 August 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 69
Open AccessFrom Monitoring to Prevention: Wearable Technology for Injury Prevention in Sport: A Narrative Review
Background Wearable technologies are used in sport to monitor training load, biomechanics, physiology, and recovery, but their effectiveness in injury prevention remains uncertain. Aim To evaluate evidence on wearables for sports injury prevention using a framework covering measurement validity, injury association, prognostic modelling, implementation, and intervention effectiveness. Material and methods A narrative review of wearables monitoring modifiable injury-related factors was conducted. Findings were organized across five translational levels, from measurement validity to injury reduction, following SANRA recommendations [20]. Results Validity and reliability depend on the device, algorithm, sensor placement, and sporting task. Associations between wearable-derived metrics and injuries are inconsistent and do not support universal risk thresholds. Machine-learning models show promise, but their use is limited by poor external validation, calibration, and methods. Implementation, organizational context, and human decision-making affect practical value. Direct evidence that wearable-guided interventions reduce injuries remains scarce. Conclusions Wearables should be viewed as monitoring and decision-support tools rather than autonomous injury-prevention systems. Evidence is strongest for measurement and weakens toward injury reduction. Future research should prioritize multicentre validation, causal modelling, standardized reporting, and pragmatic trials.
- Open Access
- 2 July 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (3(51))
ADOLESCENT BODY DYSMORPHIC DISORDER IN THE MODERN SOCIAL LANDSCAPE: A REVIEW OF CURRENT LITERATURE
Background and Aim: Body Dysmorphic Disorder (BDD) is a debilitating psychiatric condition that is increasingly affecting adolescents, largely exacerbated by the modern digital and social landscape. The aim of this article is to provide a comprehensive review of the current literature regarding the psychosocial risk factors, severe consequences, and diagnostic screening tools associated with adolescent BDD. Methodology: A narrative review of the current literature was conducted. The analysis synthesized recent studies, clinical guidelines, and theoretical papers focusing on the intersection of adolescent BDD, digital environments, peer dynamics, psychiatric risks, and diagnostic practices. Results: The reviewed literature indicates that social media exposure, peer dynamics, and bullying (including cyberbullying) serve as primary risk factors that trigger and intensify BDD symptoms in youth. The analysis also highlights severe psychosocial threats, demonstrating a concerning correlation between untreated adolescent BDD, self-injurious behaviors, and suicidality. Furthermore, the review identifies and evaluates the most effective, evidence-based screening scales currently recommended for early detection of the disorder. Conclusion: The modern social landscape significantly amplifies the risk and severity of BDD among adolescents. Due to the high risk of severe, life-threatening outcomes, there is an urgent need for heightened clinical awareness and the routine implementation of standardized screening protocols by healthcare professionals and educators to ensure early identification and intervention.
- 2 July 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (3(51))
Open AccessADOLESCENT BODY DYSMORPHIC DISORDER IN THE MODERN SOCIAL LANDSCAPE: A REVIEW OF CURRENT LITERATURE
Background and Aim: Body Dysmorphic Disorder (BDD) is a debilitating psychiatric condition that is increasingly affecting adolescents, largely exacerbated by the modern digital and social landscape. The aim of this article is to provide a comprehensive review of the current literature regarding the psychosocial risk factors, severe consequences, and diagnostic screening tools associated with adolescent BDD. Methodology: A narrative review of the current literature was conducted. The analysis synthesized recent studies, clinical guidelines, and theoretical papers focusing on the intersection of adolescent BDD, digital environments, peer dynamics, psychiatric risks, and diagnostic practices. Results: The reviewed literature indicates that social media exposure, peer dynamics, and bullying (including cyberbullying) serve as primary risk factors that trigger and intensify BDD symptoms in youth. The analysis also highlights severe psychosocial threats, demonstrating a concerning correlation between untreated adolescent BDD, self-injurious behaviors, and suicidality. Furthermore, the review identifies and evaluates the most effective, evidence-based screening scales currently recommended for early detection of the disorder. Conclusion: The modern social landscape significantly amplifies the risk and severity of BDD among adolescents. Due to the high risk of severe, life-threatening outcomes, there is an urgent need for heightened clinical awareness and the routine implementation of standardized screening protocols by healthcare professionals and educators to ensure early identification and intervention.
- Open Access
- 30 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (2(50))
SEMAGLUTIDE IN OBESITY AND EXERCISE MEDICINE: A REVIEW OF CLINICAL EVIDENCE, PERFORMANCE IMPLICATIONS, AND IMPLEMENTATION CHALLENGES
Background. Obesity is a growing global public health issue. Semaglutide (Ozempic), a glucagon-like peptide-1 receptor agonist (GLP-1 RA), represents a breakthrough in obesity pharmacotherapy, with documented benefits in weight reduction, metabolic control, and cardiovascular risk reduction. Aim. To review key clinical evidence on semaglutide in obesity treatment, explain its mechanism of action, and discuss practical aspects of implementing semaglutide therapy in Poland, including accessibility and long-term use, with particular emphasis on integration with physical activity and rehabilitation. Material and methods. The article is based on a narrative synthesis of existing sources, including key clinical trials, meta-analyses, international recommendations, and Polish regulatory and reimbursement documents concerning semaglutide use in obesity. Conclusions. Semaglutide is an effective and innovative pharmacological option in obesity management, with additional potential benefits for physical activity tolerance and weight-related rehabilitation in both recreationally active and sedentary individuals. Optimal long-term outcomes require combining semaglutide therapy with comprehensive lifestyle interventions, particularly structured exercise programs, while addressing challenges of accessibility and long-term treatment in Poland.
- 30 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (2(50))
Open AccessSEMAGLUTIDE IN OBESITY AND EXERCISE MEDICINE: A REVIEW OF CLINICAL EVIDENCE, PERFORMANCE IMPLICATIONS, AND IMPLEMENTATION CHALLENGES
Background. Obesity is a growing global public health issue. Semaglutide (Ozempic), a glucagon-like peptide-1 receptor agonist (GLP-1 RA), represents a breakthrough in obesity pharmacotherapy, with documented benefits in weight reduction, metabolic control, and cardiovascular risk reduction. Aim. To review key clinical evidence on semaglutide in obesity treatment, explain its mechanism of action, and discuss practical aspects of implementing semaglutide therapy in Poland, including accessibility and long-term use, with particular emphasis on integration with physical activity and rehabilitation. Material and methods. The article is based on a narrative synthesis of existing sources, including key clinical trials, meta-analyses, international recommendations, and Polish regulatory and reimbursement documents concerning semaglutide use in obesity. Conclusions. Semaglutide is an effective and innovative pharmacological option in obesity management, with additional potential benefits for physical activity tolerance and weight-related rehabilitation in both recreationally active and sedentary individuals. Optimal long-term outcomes require combining semaglutide therapy with comprehensive lifestyle interventions, particularly structured exercise programs, while addressing challenges of accessibility and long-term treatment in Poland.
- Open Access
- 30 December 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (4(48))
TESTOSTERONE REPLACEMENT THERAPY IN MEN WITH HYPOGONADISM – REVIEW OF LITERATURE
Testosterone replacement therapy (TRT) is the fundamental intervention in the treatment of male hypogonadism. Despite many years of clinical experience, in recent years the benefits and risks of TRT have been intensely discussed. The aim of this review article is to summarize the current state of knowledge on the pathophysiology of hypogonadism, diagnostic criteria, indications and effects of therapy, taking into account different patient groups. An analysis of available scientific publications was conducted, including clinical trials, meta-analyses, and official expert guidelines. The results of the review indicate that testosterone therapy significantly improves sexual function in men (including libido and erection) and has a beneficial effect on well-being. An increase in muscle mass, improvement in body composition (increase in lean mass and reduction of visceral fat), and also an increase in bone mineral density were observed. At the same time, attention is drawn to possible adverse effects of TRT, such as the development of polycythemia (elevated hematocrit), inhibition of sperm production, and potential exacerbation of obstructive sleep apnea symptoms in some patients. Testosterone therapy can bring significant benefits in the treatment of hypogonadism, especially in terms of improving sexual function and overall quality of life. However, the choice of treatment should be tailored to the patient in each case, taking into account possible risks, such as cardiovascular risk or impact on fertility. Due to remaining uncertainties, further prospective studies are necessary to more precisely assess the long-term safety of testosterone therapy.
- 30 December 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (4(48))
Open AccessTESTOSTERONE REPLACEMENT THERAPY IN MEN WITH HYPOGONADISM – REVIEW OF LITERATURE
Testosterone replacement therapy (TRT) is the fundamental intervention in the treatment of male hypogonadism. Despite many years of clinical experience, in recent years the benefits and risks of TRT have been intensely discussed. The aim of this review article is to summarize the current state of knowledge on the pathophysiology of hypogonadism, diagnostic criteria, indications and effects of therapy, taking into account different patient groups. An analysis of available scientific publications was conducted, including clinical trials, meta-analyses, and official expert guidelines. The results of the review indicate that testosterone therapy significantly improves sexual function in men (including libido and erection) and has a beneficial effect on well-being. An increase in muscle mass, improvement in body composition (increase in lean mass and reduction of visceral fat), and also an increase in bone mineral density were observed. At the same time, attention is drawn to possible adverse effects of TRT, such as the development of polycythemia (elevated hematocrit), inhibition of sperm production, and potential exacerbation of obstructive sleep apnea symptoms in some patients. Testosterone therapy can bring significant benefits in the treatment of hypogonadism, especially in terms of improving sexual function and overall quality of life. However, the choice of treatment should be tailored to the patient in each case, taking into account possible risks, such as cardiovascular risk or impact on fertility. Due to remaining uncertainties, further prospective studies are necessary to more precisely assess the long-term safety of testosterone therapy.
- Open Access
- 30 December 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (4(48))
EVALUATING THE SAFETY OF HOME BIRTH IN THE MODERN HEALTHCARE CONTEXT: EVIDENCE FROM INTERNATIONAL RESEARCH
The choice between home birth and hospital birth remains a topic of considerable discussion within contemporary obstetrics. The choice of birth setting and the characteristics of women opting for home birth vary across different regions of the world. In developed countries, hospitals are the default place of birth, whereas in developing countries, childbirth more often occurs at home. One of the most important criteria for comparing home and hospital births is the safety of both the mother and the newborn. The comparison of home and hospital births among low-risk women shows similar neonatal safety, with lower NICU (Neonatal Intensive Care Unit) admissions and intervention rates in home births. Mothers delivering at home experience fewer cesarean sections, episiotomies, and postpartum complications. However, outcomes vary regionally, with U.S. studies reporting higher neonatal risks in planned home births. Transfer to hospital rates range from 10-30%, mainly due to slow labour. VBACs (Vaginal Birth After Cesarean) at home are associated with lower cesarean rates but higher non-urgent transfers. Postpartum outcomes, including breastfeeding success, are superior after home birth. Evidence suggests that, in integrated systems, home birth can be a safe and informed choice.
- 30 December 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (4(48))
Open AccessEVALUATING THE SAFETY OF HOME BIRTH IN THE MODERN HEALTHCARE CONTEXT: EVIDENCE FROM INTERNATIONAL RESEARCH
The choice between home birth and hospital birth remains a topic of considerable discussion within contemporary obstetrics. The choice of birth setting and the characteristics of women opting for home birth vary across different regions of the world. In developed countries, hospitals are the default place of birth, whereas in developing countries, childbirth more often occurs at home. One of the most important criteria for comparing home and hospital births is the safety of both the mother and the newborn. The comparison of home and hospital births among low-risk women shows similar neonatal safety, with lower NICU (Neonatal Intensive Care Unit) admissions and intervention rates in home births. Mothers delivering at home experience fewer cesarean sections, episiotomies, and postpartum complications. However, outcomes vary regionally, with U.S. studies reporting higher neonatal risks in planned home births. Transfer to hospital rates range from 10-30%, mainly due to slow labour. VBACs (Vaginal Birth After Cesarean) at home are associated with lower cesarean rates but higher non-urgent transfers. Postpartum outcomes, including breastfeeding success, are superior after home birth. Evidence suggests that, in integrated systems, home birth can be a safe and informed choice.
- Open Access
- 29 December 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (4(48))
WHEN COPD ISN’T COPD: A FOURTEEN-YEAR CASE STUDY OF ADULT-ONSET SWYER-JAMES-MACLEOD SYNDROME
Swyer-James-MacLeod (SJML) syndrome, also known as unilateral hyperlucent lung syndrome, is a rare post-infectious pulmonary disorder characterized by emphysematous changes, unilateral pulmonary artery hypoplasia, and regional hypoperfusion [1, 2]. The hallmark radiographic feature - often referred to as the “hyperlucent lung” or “clear lung sign” - reflects air trapping with decreased vascular markings and serves as the signature diagnostic clue of this condition [3, 6]. SJML syndrome typically develops following childhood bronchiolitis or pneumonitis but may remain unrecognized until adulthood due to its nonspecific respiratory presentation [4, 7]. We report the case of a 41-year-old woman who has been under observation and treatment for the past 14 years. Despite chronic, non-productive cough and persistent unilateral pulmonary abnormalities, she was not initially diagnosed with SJML syndrome due to the absence of standardized diagnostic criteria. Radiological assessment, including high-resolution computed tomography (HRCT) and CT angiography, revealed a hyperlucent and volume-reduced left lung with bronchiectasic changes and pulmonary arterial hypoplasia, findings consistent with described syndrome. Pulmonary function tests demonstrated moderate airflow obstruction, while the patient’s prolonged childhood exposure to tobacco smoke may have contributed to airway remodeling. This long-term follow-up highlights the diagnostic importance of recognizing unilateral hyperlucency as the signature sign of SJML syndrome and underscores the need for multidisciplinary monitoring to optimize long-term respiratory outcomes [5–7].
- 29 December 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (4(48))
Open AccessWHEN COPD ISN’T COPD: A FOURTEEN-YEAR CASE STUDY OF ADULT-ONSET SWYER-JAMES-MACLEOD SYNDROME
Swyer-James-MacLeod (SJML) syndrome, also known as unilateral hyperlucent lung syndrome, is a rare post-infectious pulmonary disorder characterized by emphysematous changes, unilateral pulmonary artery hypoplasia, and regional hypoperfusion [1, 2]. The hallmark radiographic feature - often referred to as the “hyperlucent lung” or “clear lung sign” - reflects air trapping with decreased vascular markings and serves as the signature diagnostic clue of this condition [3, 6]. SJML syndrome typically develops following childhood bronchiolitis or pneumonitis but may remain unrecognized until adulthood due to its nonspecific respiratory presentation [4, 7]. We report the case of a 41-year-old woman who has been under observation and treatment for the past 14 years. Despite chronic, non-productive cough and persistent unilateral pulmonary abnormalities, she was not initially diagnosed with SJML syndrome due to the absence of standardized diagnostic criteria. Radiological assessment, including high-resolution computed tomography (HRCT) and CT angiography, revealed a hyperlucent and volume-reduced left lung with bronchiectasic changes and pulmonary arterial hypoplasia, findings consistent with described syndrome. Pulmonary function tests demonstrated moderate airflow obstruction, while the patient’s prolonged childhood exposure to tobacco smoke may have contributed to airway remodeling. This long-term follow-up highlights the diagnostic importance of recognizing unilateral hyperlucency as the signature sign of SJML syndrome and underscores the need for multidisciplinary monitoring to optimize long-term respiratory outcomes [5–7].
- Open Access
- 25 December 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (4(48))
NUTRITIONAL AND ENVIRONMENTAL FACTORS DETERMINING DHA STATUS IN PREGNANT AND LACTATING WOMEN: IMPLICATIONS FOR MATERNAL AND NEONATAL HEALTH
The intake of omega-3 polyunsaturated fatty acids, particularly docosahexaenoic acid (DHA), is essential for the proper development of the fetus and for maintaining the health and well-being of the pregnant woman, as well as of both the mother and the infant during the lactation period. Numerous studies have demonstrated the beneficial effects of DHA on the development of the nervous system and retinal function, as well as its role in reducing the risk of preeclampsia, preterm delivery, low birth weight, postpartum depression, perinatal maternal mortality, and neonatal intensive care unit admissions. Moreover, DHA has been shown to positively influence the clinical course of certain neonatal disorders after birth. Available data suggest that the dietary and supplemental intake of DHA among pregnant women in Poland may be insufficient compared with current nutritional recommendations. The richest dietary sources of DHA include fatty fish and seafood; however, it is advisable to select species with the lowest levels of methylmercury contamination. Storage and thermal processing affect the omega-3 content in food. Vegetarian women may be particularly susceptible to DHA deficiency. Dietary supplementation with DHA derived from controlled microalgae cultures or fish oils can effectively compensate for inadequate intake. Maintaining an appropriate balance between omega-3 and omega-6 fatty acid consumption is crucial. It is also hypothesized that eicosapentaenoic acid (EPA) may be required for the efficient utilization of DHA by the fetus and may contribute to a reduced risk of preterm birth and preeclampsia. Consumption of DHA increases the risk of macrosomia in the fetus and may influence the extension of pregnancy beyond 42 weeks.
- 25 December 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (4(48))
Open AccessNUTRITIONAL AND ENVIRONMENTAL FACTORS DETERMINING DHA STATUS IN PREGNANT AND LACTATING WOMEN: IMPLICATIONS FOR MATERNAL AND NEONATAL HEALTH
The intake of omega-3 polyunsaturated fatty acids, particularly docosahexaenoic acid (DHA), is essential for the proper development of the fetus and for maintaining the health and well-being of the pregnant woman, as well as of both the mother and the infant during the lactation period. Numerous studies have demonstrated the beneficial effects of DHA on the development of the nervous system and retinal function, as well as its role in reducing the risk of preeclampsia, preterm delivery, low birth weight, postpartum depression, perinatal maternal mortality, and neonatal intensive care unit admissions. Moreover, DHA has been shown to positively influence the clinical course of certain neonatal disorders after birth. Available data suggest that the dietary and supplemental intake of DHA among pregnant women in Poland may be insufficient compared with current nutritional recommendations. The richest dietary sources of DHA include fatty fish and seafood; however, it is advisable to select species with the lowest levels of methylmercury contamination. Storage and thermal processing affect the omega-3 content in food. Vegetarian women may be particularly susceptible to DHA deficiency. Dietary supplementation with DHA derived from controlled microalgae cultures or fish oils can effectively compensate for inadequate intake. Maintaining an appropriate balance between omega-3 and omega-6 fatty acid consumption is crucial. It is also hypothesized that eicosapentaenoic acid (EPA) may be required for the efficient utilization of DHA by the fetus and may contribute to a reduced risk of preterm birth and preeclampsia. Consumption of DHA increases the risk of macrosomia in the fetus and may influence the extension of pregnancy beyond 42 weeks.
- Open Access
- 23 December 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (4(48))
NUTRITIONAL FACTORS AND THEIR ROLE IN MENTAL HEALTH - A CLINICAL REVIEW
The aim of this study was to review the current scientific evidence on the effects of selected nutrients on mental health in the general population. Randomized controlled trials, metaanalyses, and systematic reviews published between 2018 and 2025 were analyzed, retrieved from the PubMed, Embase, and Google Scholar databases. The review considered associations between the intake of omega-3 fatty acids, B-group vitamins, vitamin D, zinc, magnesium, probiotics, prebiotics, and antioxidants (vitamins C, E, carotenoids, and polyphenols) and the occurrence of depressive, anxiety, and cognitive symptoms. Literature data indicate that deficiencies of these nutrients may affect neurotransmitter function, neuronal plasticity, inflammatory processes, and oxidative stress, linking diet to the pathophysiological mechanisms of mood disorders. Supplementation with omega-3 fatty acids, folic acid, magnesium, zinc, vitamin D, and selected probiotics demonstrated moderate improvement in mood and reduction of anxiety symptoms in most analyzed studies, while the results for vitamins C, E, and B₁₂ remain inconclusive. Beneficial effects of curcumin and βcarotene were also observed in reducing oxidative stress and improving psychological wellbeing. The collected data suggest that an adequate supply of micronutrients and antiinflammatory components may support mental health, but the current evidence is limited by small sample sizes, short observation periods, and heterogeneity of interventions. In clinical practice, a balanced diet remains essential, while supplementation should be individualized and applied in cases of confirmed deficiency. This article summarizes the current state of knowledge and indicates directions for future research.
- 23 December 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (4(48))
Open AccessNUTRITIONAL FACTORS AND THEIR ROLE IN MENTAL HEALTH - A CLINICAL REVIEW
The aim of this study was to review the current scientific evidence on the effects of selected nutrients on mental health in the general population. Randomized controlled trials, metaanalyses, and systematic reviews published between 2018 and 2025 were analyzed, retrieved from the PubMed, Embase, and Google Scholar databases. The review considered associations between the intake of omega-3 fatty acids, B-group vitamins, vitamin D, zinc, magnesium, probiotics, prebiotics, and antioxidants (vitamins C, E, carotenoids, and polyphenols) and the occurrence of depressive, anxiety, and cognitive symptoms. Literature data indicate that deficiencies of these nutrients may affect neurotransmitter function, neuronal plasticity, inflammatory processes, and oxidative stress, linking diet to the pathophysiological mechanisms of mood disorders. Supplementation with omega-3 fatty acids, folic acid, magnesium, zinc, vitamin D, and selected probiotics demonstrated moderate improvement in mood and reduction of anxiety symptoms in most analyzed studies, while the results for vitamins C, E, and B₁₂ remain inconclusive. Beneficial effects of curcumin and βcarotene were also observed in reducing oxidative stress and improving psychological wellbeing. The collected data suggest that an adequate supply of micronutrients and antiinflammatory components may support mental health, but the current evidence is limited by small sample sizes, short observation periods, and heterogeneity of interventions. In clinical practice, a balanced diet remains essential, while supplementation should be individualized and applied in cases of confirmed deficiency. This article summarizes the current state of knowledge and indicates directions for future research.
- Open Access
- 22 December 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (4(48))
STRESS, PERSONALITY AND MIGRAINE. A REVIEW OF PSYCHOSOCIAL AND NEUROPHYSIOLOGICAL RISK FACTORS
Migraine is a complex neurological and psychological condition that causes repeated headache attacks, sensitivity to light and sound, and major effects on quality of life. Modern research shows that migraine develops from the interaction between biological sensitivity, stress, and personality traits. This review combines findings from neuroscience, psychology, and clinical studies to explain how stress reactivity, emotional regulation, and coping style affect migraine onset and management. Understanding these biological and psychosocial links can improve treatment and support more effective combined approaches that use both medication and psychotherapy.
- 22 December 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (4(48))
Open AccessSTRESS, PERSONALITY AND MIGRAINE. A REVIEW OF PSYCHOSOCIAL AND NEUROPHYSIOLOGICAL RISK FACTORS
Migraine is a complex neurological and psychological condition that causes repeated headache attacks, sensitivity to light and sound, and major effects on quality of life. Modern research shows that migraine develops from the interaction between biological sensitivity, stress, and personality traits. This review combines findings from neuroscience, psychology, and clinical studies to explain how stress reactivity, emotional regulation, and coping style affect migraine onset and management. Understanding these biological and psychosocial links can improve treatment and support more effective combined approaches that use both medication and psychotherapy.